Patent watch

October 2002
Nature Reviews Drug Discovery;Oct2002, Vol. 1 Issue 10, p750
Academic Journal
Reports on developments concerning patents in Europe and the United States as of October 2002. Oral proceedings of the Opposition Division of the European Patent Office concerning the use of genetic engineering to isolate stem cells from more differentiated cells to obtain pure stem-cell cultures; U.S. Patent Office's prioritization of a Genentech-University of Pennsylvania patent application relating to anti-HER2 antibodies over a related Chiron patent.


Related Articles

  • Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. McDonald, John W.; Liu, Xiao-Zhong; Qu, Yun; Liu, Su; Mickey, Shannon K.; Turetsky, Dorothy; Gottlieb, David I.; Choi, Dennis W. // Nature Medicine;Dec1999, Vol. 5 Issue 12, p1410 

    Transplantation approaches using cellular bridges, fetal central nervous system cells, fibroblasts expressing neurotrophin-3 (ref. 6), hybridoma cells expressing inhibitory protein-blocking antibodies, or olfactory nerves ensheathing glial cells transplanted into the acutely injured spinal cord...

  • Opponents of stem-cell patent win restrictions. Abbott, Alison; Schmidt, Oliver // Nature;8/1/2002, Vol. 418 Issue 6897, p470 

    Reports on the restriction in the scope of patent covering technologies for purifying human and animal embryonic stem cells by the European Patent Office in 2002. Details of the patent coverage; Groups that filed objections to the patent; Claim against the methods involved in the patent; Basis...

  • Embryonic Stem Cell Patents and Human Dignity. David Resnik // Health Care Analysis;Sep2007, Vol. 15 Issue 3, p211 

    Abstract  This article examines the assertion that human embryonic stem cells patents are immoral because they violate human dignity. After analyzing the concept of human dignity and its role in bioethics debates, this article argues that patents on human embryos or totipotent...

  • 'No' to ban on stem-cell patents. Smith, Austin // Nature;4/28/2011, Vol. 472 Issue 7344, p418 

    A letter to the editor is presented regarding the recommendation of the advocate-general of the European Court of Justice to prohibit ethical grounds on human embryonic stem cell patents.

  • More at stake in stem-cell patents. Jones, David Albert // Nature;6/30/2011, Vol. 474 Issue 7353, p579 

    A letter to the editor is presented in response to the article by Austin Smith and colleagues on human embryonic stem cell patents in the 2011 issue.

  • An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Tang, Chad; Lee, Andrew S; Volkmer, Jens-Peter; Sahoo, Debashis; Nag, Divya; Mosley, Adriane R; Inlay, Matthew A; Ardehali, Reza; Chavez, Shawn L; Pera, Renee Reijo; Behr, Barry; Wu, Joseph C; Weissman, Irving L; Drukker, Micha // Nature Biotechnology;Sep2011, Vol. 29 Issue 9, p829 

    An important risk in the clinical application of human pluripotent stem cells (hPSCs), including human embryonic and induced pluripotent stem cells (hESCs and hiPSCs), is teratoma formation by residual undifferentiated cells. We raised a monoclonal antibody against hESCs, designated...

  • The Histone H2A Variant MacroH2A1 Does Not Localize to the Centrosome. Friedman, Nathalie; Barzily-Rokni, Michal; Isaac, Sara; Eden, Amir // PLoS ONE;2011, Vol. 6 Issue 2, p1 

    MacroH2A1 is a histone H2A variant which contains a large non-histone C-terminal region of largely unknown function. Within this region is a macro domain which can bind ADP-ribose and related molecules. Most studies of macroH2A1 focus on the involvement of this variant in transcriptional...

  • Trends in the Human Embryonic Stem Cell Patent Field. Karlsson, Ulrika; Hyllner, Johan; Runeberg, Kristina // Recent Patents on Nanotechnology;Nov2007, Vol. 1 Issue 3, p233 

    The successful derivation of human embryonic stem (hES) cell lines in late 1990s marks the birth of a new era in biomedical research. In the USA, this landmark invention is protected by granted composition-of-matter patents. In addition to these patents, several others have been granted on...

  • Recent patent applications in stem cell research.  // Nature Biotechnology;Apr2006, Vol. 24 Issue 4, p414 

    The article presents a list of recent patent applications in stem cell research. The subjects of the patents include a method of regulating cell function of a stem cell, a commercial product for culturing human embryonic stem cells, and a method of producing a marker capable of identifying an...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics